NewEdge Wealth’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$517K Buy
5,113
+681
+15% +$70.5K 0.01% 848
2026
Q1
$429K Buy
4,432
+651
+17% +$66.8K 0.01% 862
2025
Q4
$401K Buy
3,781
+393
+12% +$45.6K ﹤0.01% 918
2025
Q3
$391K Sell
3,388
-77
-2% -$9.17K 0.01% 812
2025
Q2
$404K Buy
3,465
+1,167
+51% +$133K 0.01% 759
2025
Q1
$233K Buy
+2,298
New +$224K ﹤0.01% 847
2022
Q1
Sell
-9,930
Closed -$516K 420
2021
Q4
$516K Buy
+9,930
New +$512K 0.02% 289

Other funds holding EHC

NewEdge Wealth's EHC Position: Q2 2026 in Review

NewEdge Wealth increased its Encompass Health (EHC) stake by 15% in Q2 2026, buying an estimated $70.5K and bringing the position to 5,113 shares worth $517K. The position accounts for 0.01% of the portfolio, ranked #848.

NewEdge Wealth first reported a position in EHC in Q4 2021 and has held it in 7 quarters since. 599 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • NewEdge Wealth held 5,113 shares of Encompass Health worth $517K as of Q2 2026.
  • NewEdge Wealth bought 681 Encompass Health shares in Q2 2026, an estimated $70.5K.
  • Encompass Health made up 0.01% of NewEdge Wealth's portfolio in Q2 2026, its #848 holding.
  • NewEdge Wealth first reported a position in Encompass Health in Q4 2021 and has held it in 7 quarters since.
  • 599 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on NewEdge Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.